ES2120251T3 - 3-alcoxicarbonil-tiadiazinonas cardioactivas. - Google Patents

3-alcoxicarbonil-tiadiazinonas cardioactivas.

Info

Publication number
ES2120251T3
ES2120251T3 ES96100093T ES96100093T ES2120251T3 ES 2120251 T3 ES2120251 T3 ES 2120251T3 ES 96100093 T ES96100093 T ES 96100093T ES 96100093 T ES96100093 T ES 96100093T ES 2120251 T3 ES2120251 T3 ES 2120251T3
Authority
ES
Spain
Prior art keywords
tiadiazinonas
alcoxicarbonil
cardioactivas
sup
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96100093T
Other languages
English (en)
Spanish (es)
Inventor
Rochus Dr Jonas
Inge Dr Lues
Norbert Dr Beier
Klaus-Otto Dr Minck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2120251T3 publication Critical patent/ES2120251T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES96100093T 1995-01-11 1996-01-05 3-alcoxicarbonil-tiadiazinonas cardioactivas. Expired - Lifetime ES2120251T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19500558A DE19500558A1 (de) 1995-01-11 1995-01-11 3-Alkoxycarbonyl-thiadiazinone

Publications (1)

Publication Number Publication Date
ES2120251T3 true ES2120251T3 (es) 1998-10-16

Family

ID=7751240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96100093T Expired - Lifetime ES2120251T3 (es) 1995-01-11 1996-01-05 3-alcoxicarbonil-tiadiazinonas cardioactivas.

Country Status (23)

Country Link
US (1) US5705497A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0721950B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP4025377B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100399541B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1055691C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE165828T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU704493B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2166854A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ292094B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE19500558A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0721950T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2120251T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3027566T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP9600061A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9600165A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO306300B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL183011B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2162087C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI0721950T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK280532B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW407157B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA44249C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA96177B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
DE19929785A1 (de) 1999-06-29 2001-01-04 Bayer Ag Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung
RU2395508C1 (ru) * 2006-05-24 2010-07-27 Лейбниц Инститьют Фор Нэчрал Продакт Рисерч Энд Инфекшн Байолоджи Е.В. Ганс-Кнёль-Институт (Хки) Новые производные бензотиазинона и их применение в качестве антибактериальных средств
RU2692102C2 (ru) * 2014-08-15 2019-06-21 Ф. Хоффманн-Ля Рош Аг 2,2,2-трифторэтил-тиадиазины
CN112500353B (zh) * 2020-12-08 2022-11-25 北京晨光同创医药研究院有限公司 一种左西孟旦的前药化合物、制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
GB8901836D0 (en) * 1989-01-27 1989-03-15 Sobio Lab Compounds
SU1648949A1 (ru) * 1989-04-25 1991-05-15 Ленинградский Технологический Институт Им.Ленсовета Способ получени 2,4,5-замещенных 4Н-1,3,4-тиадиазинов
DE4041074A1 (de) * 1990-12-21 1992-06-25 Merck Patent Gmbh Thiadiazinonderivate
DE4129062A1 (de) * 1991-09-02 1993-03-04 Merck Patent Gmbh Verfahren zur enantiomerentrennung von 5-hetaryl-1,3,4-thiadiazinonen
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
DE4223537A1 (de) * 1992-07-17 1994-01-20 Merck Patent Gmbh Thiadiazinone
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone

Also Published As

Publication number Publication date
NO306300B1 (no) 1999-10-18
EP0721950A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-07-24
DE59600173D1 (de) 1998-06-10
SK165295A3 (en) 1996-08-07
NO960112L (no) 1996-07-12
CN1135484A (zh) 1996-11-13
JP4025377B2 (ja) 2007-12-19
NO960112D0 (no) 1996-01-10
KR960029331A (ko) 1996-08-17
HK1010194A1 (en) 1999-06-17
TW407157B (en) 2000-10-01
SI0721950T1 (en) 1998-10-31
DK0721950T3 (da) 1999-02-15
GR3027566T3 (en) 1998-11-30
UA44249C2 (uk) 2002-02-15
CA2166854A1 (en) 1996-07-12
CN1055691C (zh) 2000-08-23
AU4082696A (en) 1996-07-18
US5705497A (en) 1998-01-06
CZ292094B6 (cs) 2003-07-16
SK280532B6 (sk) 2000-03-13
RU2162087C2 (ru) 2001-01-20
ATE165828T1 (de) 1998-05-15
PL312240A1 (en) 1996-07-22
DE19500558A1 (de) 1996-07-18
PL183011B1 (pl) 2002-05-31
KR100399541B1 (ko) 2003-12-31
CZ8096A3 (en) 1996-07-17
HUP9600061A3 (en) 1998-04-28
ZA96177B (en) 1996-07-30
JPH08253478A (ja) 1996-10-01
EP0721950A2 (de) 1996-07-17
MX9600165A (es) 1997-01-31
AU704493B2 (en) 1999-04-22
HUP9600061A2 (en) 1997-10-28
EP0721950B1 (de) 1998-05-06

Similar Documents

Publication Publication Date Title
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
FI973255A7 (fi) Karbatsoliyhdisteiden käyttö verentungosta aiheuttavan sydämen toiminnanvajauksen hoidossa
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
ES537769A0 (es) Protesis cardiaca total que incluye dos bombas desacopladas asociadas en una unidad funcional indisociable
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
NO930615D0 (no) Hypoglykemiske hydroksyurinstoffderivater
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
ES2191070T3 (es) Arilalquil-piridazinonas.
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
ES2088574T3 (es) Derivado de anilida.
ATE79761T1 (de) Behandlung einer krankheit vom aids-typ.
NO950784L (no) Fettsyrederivater
DE69230037D1 (de) Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien
MY102323A (en) New ribofuranuronic acid derivatives
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
ES2120251T3 (es) 3-alcoxicarbonil-tiadiazinonas cardioactivas.
PT783495E (pt) Derivados de quinoxalina uteis em terapia
NO950909L (no) Nitrogensubstituert acridin og inhibitorer for cytochrome P450 og metoder for anvendelse
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
NZ308260A (en) Use of 5-(substituted biphenyl)-tetrazole derivatives to treat multiple system organ failure
LV11882A (lv) Aminotetralina atvasinajumi sirds un asinsvadu slimibu arstesana
ATE10361T1 (de) Derivate von 3-phenoxy-2-propanolen, ihre herstellung und ihre therapeutische verwendung.
DK0468258T3 (da) Substituerede pyridooxaziner
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
MX9604019A (es) Derivados de biotina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 721950

Country of ref document: ES